Bielefeld Pub
metadata only
Baseline C-reactive protein independently predicts treatment response and survival in metastatic melanoma patients receiving first-line immune checkpoint inhibitors
Gambichler T, Ruhe C, Weyer-Fahlbusch SS, Susok L, Abu Rached N. Baseline C-reactive protein independently predicts treatment response and survival in metastatic melanoma patients receiving first-line immune checkpoint inhibitors. European Journal of Dermatology. 2026;36(4):384-386.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab#900625
- SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients#848270
- A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma#878483
- Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics#1008216
- Gut microbial markers of immunotherapy response in melanoma: a cross-cohort analysis including the first Russian dataset.#288690
Record · ID 1028844
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive